IL DONG PHARMACEUTICAL CO., LTD. Logo

IL DONG PHARMACEUTICAL CO., LTD.

Develops, manufactures, and commercializes a broad range of healthcare products.

249420 | KO

Overview

Corporate Details

ISIN(s):
KR7249420001
LEI:
Country:
South Korea
Address:
서울특별시 서초구 바우뫼로27길 2, 서초구

Description

IL DONG PHARMACEUTICAL CO., LTD. is a pharmaceutical company engaged in the research, development, manufacturing, and commercialization of a broad range of healthcare products. The company's portfolio encompasses ethical drugs, over-the-counter (OTC) medications, active pharmaceutical ingredients (APIs), and health functional foods. Key therapeutic areas of focus include metabolic disorders, gastrointestinal diseases, degenerative diseases, oncology, and cardiovascular conditions. Its robust research and development pipeline features promising drug candidates such as an oral GLP-1 receptor agonist for diabetes and obesity, a P-CAB class treatment for peptic ulcers, and a first-in-class CXCR7 agonist for fibrotic diseases. Utilizing its GMP-certified facilities, the company also offers contract manufacturing (CMO) services, with specialized capabilities in antibiotics and oncology drugs, while actively pursuing global expansion through strategic partnerships and licensing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-05-10 00:00
[기재정정]타인에대한채무보증결정
Korean 24.7 KB
2023-05-10 00:00
영업(잠정)실적(공정공시)
Korean 13.4 KB
2023-05-03 00:00
결산실적공시예고(안내공시)
Korean 4.4 KB
2023-03-24 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.5 KB
2023-03-24 00:00
정기주주총회결과
Korean 24.9 KB
2023-03-23 00:00
주식등의대량보유상황보고서(일반)
Korean 141.1 KB
2023-03-23 00:00
최대주주등소유주식변동신고서
Korean 57.9 KB
2023-03-16 00:00
감사보고서제출
Korean 19.8 KB
2023-03-16 00:00
사업보고서 (2022.12)
Korean 2.3 MB
2023-03-09 00:00
주주총회소집공고
Korean 1.4 MB
2023-03-09 00:00
주주총회집중일개최사유신고
Korean 4.9 KB
2023-02-09 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 17.8 KB
2023-02-09 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 14.0 KB
2023-02-09 00:00
영업(잠정)실적(공정공시)
Korean 13.4 KB
2023-02-09 00:00
주주총회소집결의
Korean 12.8 KB

Automate Your Workflow. Get a real-time feed of all IL DONG PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IL DONG PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IL DONG PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.